News FDA & Regulatory, Insurance, Medicare Kimberly Juroviesky 8/1/26 FDA & Regulatory, Insurance, Medicare Kimberly Juroviesky 8/1/26 August 2026 - Taskforce Speaks at FDA Meeting on Ketamine Repurposing Read More Research, Insurance, Medicare Kimberly Juroviesky 12/1/25 Research, Insurance, Medicare Kimberly Juroviesky 12/1/25 December 2025 - Launching a Study on Safety and Efficacy for Seniors Read More Insurance, Medicare Kimberly Juroviesky 7/1/24 Insurance, Medicare Kimberly Juroviesky 7/1/24 July 2024 - Targeting Employer Insurance and State Medicare Coverage Read More FDA & Regulatory, Medicare Kimberly Juroviesky 1/1/23 FDA & Regulatory, Medicare Kimberly Juroviesky 1/1/23 January 2023 - After Medicare Setback, Ketamine Taskforce Pivots to Pursue FDA Approval Read More Medicare Kimberly Juroviesky 11/1/22 Medicare Kimberly Juroviesky 11/1/22 November 2022 - A Major Milestone: Our NCD Application Is Now with Medicare Read More
FDA & Regulatory, Insurance, Medicare Kimberly Juroviesky 8/1/26 FDA & Regulatory, Insurance, Medicare Kimberly Juroviesky 8/1/26 August 2026 - Taskforce Speaks at FDA Meeting on Ketamine Repurposing Read More
Research, Insurance, Medicare Kimberly Juroviesky 12/1/25 Research, Insurance, Medicare Kimberly Juroviesky 12/1/25 December 2025 - Launching a Study on Safety and Efficacy for Seniors Read More
Insurance, Medicare Kimberly Juroviesky 7/1/24 Insurance, Medicare Kimberly Juroviesky 7/1/24 July 2024 - Targeting Employer Insurance and State Medicare Coverage Read More
FDA & Regulatory, Medicare Kimberly Juroviesky 1/1/23 FDA & Regulatory, Medicare Kimberly Juroviesky 1/1/23 January 2023 - After Medicare Setback, Ketamine Taskforce Pivots to Pursue FDA Approval Read More
Medicare Kimberly Juroviesky 11/1/22 Medicare Kimberly Juroviesky 11/1/22 November 2022 - A Major Milestone: Our NCD Application Is Now with Medicare Read More
